[HTML] frontiersin.org

[HTML][HTML] Kidney cancer models for pre-clinical drug discovery: challenges and opportunities

L Pohl, J Friedhoff, C Jurcic, M Teroerde… - Frontiers in …, 2022 - frontiersin.org
Renal cell carcinoma (RCC) is among the most lethal urological malignancies once
metastatic. The introduction of immune checkpoint inhibitors has revolutionized the …
被引用次数：3 相关文章
[PDF] academia.edu

[PDF][PDF] Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities. Front

L Pohl, J Friedhoff, C Jurcic, M Teroerde, I Schindler… - Oncol, 2022 - academia.edu
Renal cell carcinoma (RCC) is among the most lethal urological malignancies once
metastatic. The introduction of immune checkpoint inhibitors has revolutionized the …
[HTML] nih.gov

[HTML][HTML] Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities

L Pohl, J Friedhoff, C Jurcic, M Teroerde… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Renal cell carcinoma (RCC) is among the most lethal urological malignancies once
metastatic. The introduction of immune checkpoint inhibitors has revolutionized the …

Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities.

L Pohl, J Friedhoff, C Jurcic, M Teroerde… - Frontiers in …, 2022 - europepmc.org
Renal cell carcinoma (RCC) is among the most lethal urological malignancies once
metastatic. The introduction of immune checkpoint inhibitors has revolutionized the …

Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities

L Pohl, J Friedhoff, C Jurcic, M Teroerde… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Renal cell carcinoma (RCC) is among the most lethal urological malignancies once
metastatic. The introduction of immune checkpoint inhibitors has revolutionized the …